Abstract
From the whole plant of Dendrobium signatum, a new bibenzyl-dihydrophenanthrene derivative, named dendrosignatol was isolated, together with the known compounds 3,4-dihydroxy-3,4'-dimethoxybibenzyl, dendrocandin B, dendrocandin I and dendrofalconerol A. The structure of the new compound was elucidated through analysis of its spectroscopic and mass spectrometric data. All of the isolates showed appreciable cytotoxic activity against three human cancer cell lines, including MDA-231, HepG2 and HT-29 cells.
| Original language | English |
|---|---|
| Pages (from-to) | 657-659 |
| Number of pages | 3 |
| Journal | Natural Product Communications |
| Volume | 11 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - May 2016 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Bibenzyl-dihydrophenanthrene
- Cytotoxicity
- Dendrobium signatum
- Orchidaceae
Fingerprint
Dive into the research topics of 'A new bibenzyl-phenanthrene derivative from Dendrobium signatum and its cytotoxic activity'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver